The Medacta International AMIStem-P Post-Marketing Surveillance Study

Prospective, Multicentre, Open Study Evaluating the Performance and Stability of the AMIStem-P Femoral Stem

This is a Post-Market Surveillance study of AMIStem-P femoral stem prosthesis

Inclusion Criteria:

• Patients with a disease (primary coxarthrosis, inflammatory arthritis of the hip, necrosis of the femoral head, etc.) requiring a total hip replacement
• Patient eligible to receive an uncemented AMIStem-P femoral stem
• Patient agreeing to comply with the study requirements
• Patient willing to provide written informed consent
• Patient affiliated to a social security system
• Patients between 18 and 85 years old

Exclusion Criteria:

• Participation in biomedical research
• Patients younger than 18 years old
• Vulnerable adult patients according to article L1121-6 of the French Public Health Code
• Pregnant or breastfeeding women
• Patients unable to provide written informed consent